[go: up one dir, main page]

AR011730A1 - UNA FORMA FARMACÉUTICA DE CANTIDADES FIJAS DE UN INIHIBIDOR DE LA ENZIMA CONVERSORA DE ANGIOTENSINA Y DE UN ANTAGONISTA DEL CANAL DE CALCIO , COMPOSICIoN FARMACÉUTICAMENTE ACEPTABLE QUE COMPRENDE DICHA FORMA FARMACÉUTICA , PROCEDIMIENTO PARA LA OBTENCIoN DE DICHA COMPOSICIoN FARMACÉUTICAMENTE ACEPTA - Google Patents

UNA FORMA FARMACÉUTICA DE CANTIDADES FIJAS DE UN INIHIBIDOR DE LA ENZIMA CONVERSORA DE ANGIOTENSINA Y DE UN ANTAGONISTA DEL CANAL DE CALCIO , COMPOSICIoN FARMACÉUTICAMENTE ACEPTABLE QUE COMPRENDE DICHA FORMA FARMACÉUTICA , PROCEDIMIENTO PARA LA OBTENCIoN DE DICHA COMPOSICIoN FARMACÉUTICAMENTE ACEPTA

Info

Publication number
AR011730A1
AR011730A1 ARP980102163A ARP980102163A AR011730A1 AR 011730 A1 AR011730 A1 AR 011730A1 AR P980102163 A ARP980102163 A AR P980102163A AR P980102163 A ARP980102163 A AR P980102163A AR 011730 A1 AR011730 A1 AR 011730A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical
pharmaceutical form
conversing
angiotensin
applicable
Prior art date
Application number
ARP980102163A
Other languages
English (en)
Original Assignee
Procter & Gamble Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8299270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR011730(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble Pharma filed Critical Procter & Gamble Pharma
Publication of AR011730A1 publication Critical patent/AR011730A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
ARP980102163A 1997-05-13 1998-05-11 UNA FORMA FARMACÉUTICA DE CANTIDADES FIJAS DE UN INIHIBIDOR DE LA ENZIMA CONVERSORA DE ANGIOTENSINA Y DE UN ANTAGONISTA DEL CANAL DE CALCIO , COMPOSICIoN FARMACÉUTICAMENTE ACEPTABLE QUE COMPRENDE DICHA FORMA FARMACÉUTICA , PROCEDIMIENTO PARA LA OBTENCIoN DE DICHA COMPOSICIoN FARMACÉUTICAMENTE ACEPTA AR011730A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701017A ES2125198B1 (es) 1997-05-13 1997-05-13 Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.

Publications (1)

Publication Number Publication Date
AR011730A1 true AR011730A1 (es) 2000-08-30

Family

ID=8299270

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102163A AR011730A1 (es) 1997-05-13 1998-05-11 UNA FORMA FARMACÉUTICA DE CANTIDADES FIJAS DE UN INIHIBIDOR DE LA ENZIMA CONVERSORA DE ANGIOTENSINA Y DE UN ANTAGONISTA DEL CANAL DE CALCIO , COMPOSICIoN FARMACÉUTICAMENTE ACEPTABLE QUE COMPRENDE DICHA FORMA FARMACÉUTICA , PROCEDIMIENTO PARA LA OBTENCIoN DE DICHA COMPOSICIoN FARMACÉUTICAMENTE ACEPTA

Country Status (23)

Country Link
EP (1) EP0884054B9 (es)
JP (1) JP3576806B2 (es)
CN (1) CN1146418C (es)
AR (1) AR011730A1 (es)
AT (1) ATE236653T1 (es)
AU (1) AU735404B2 (es)
BR (1) BR9805597A (es)
CA (1) CA2234899C (es)
CZ (1) CZ292616B6 (es)
DE (1) DE69813083T2 (es)
DK (1) DK0884054T3 (es)
ES (2) ES2125198B1 (es)
HU (1) HUP9801075A3 (es)
IL (1) IL124253A (es)
NO (1) NO315545B1 (es)
NZ (1) NZ330447A (es)
PL (1) PL192117B1 (es)
PT (1) PT884054E (es)
RU (1) RU2182002C2 (es)
SK (1) SK284337B6 (es)
TR (1) TR199800847A3 (es)
TW (1) TW562679B (es)
ZA (1) ZA983806B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
MXPA02010040A (es) * 2000-04-11 2004-10-15 Sankyo Co Composiciones farmaceuticas estabilizadas que contienen bloqueadores de canal de calcio.
CN100509058C (zh) * 2001-01-26 2009-07-08 先灵公司 过氧化物酶体增殖物激活受体(ppar)活化剂和甾醇吸收抑制剂的组合药以及对于血管适应症的治疗
ME00076B (me) * 2002-12-16 2011-02-10 Kissei Pharmaceutical Lijek u čvrstom obliku za oralnu primjenu
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法
CN109985013B (zh) * 2019-05-10 2021-08-10 河北君圣药业有限公司 一种尼群地平分散片及其制备方法
CN115501224A (zh) * 2022-10-09 2022-12-23 南昌大学第一附属医院 马来酸依那普利叶酸片联合通心络在制备治疗高血压合并颈动脉硬化药物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
USH734H (en) * 1988-03-07 1990-02-06 E. R. Squibb & Sons, Inc. Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
SI9111842A (sl) * 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
BR9805597A (pt) 2000-04-11
NO315545B1 (no) 2003-09-22
CN1146418C (zh) 2004-04-21
AU735404B2 (en) 2001-07-05
ES2197443T3 (es) 2004-01-01
ES2125198A1 (es) 1999-02-16
DE69813083D1 (de) 2003-05-15
HUP9801075A3 (en) 2000-12-28
AU6597398A (en) 1998-11-19
DE69813083T2 (de) 2004-05-27
NO982112L (no) 1998-11-16
NO982112D0 (no) 1998-05-08
TR199800847A2 (xx) 1999-10-21
PL192117B1 (pl) 2006-09-29
DK0884054T3 (da) 2003-07-21
CZ292616B6 (cs) 2003-11-12
PT884054E (pt) 2003-08-29
RU2182002C2 (ru) 2002-05-10
NZ330447A (en) 1998-12-23
CA2234899A1 (en) 1998-11-13
TR199800847A3 (tr) 1999-10-21
TW562679B (en) 2003-11-21
JP3576806B2 (ja) 2004-10-13
JPH11124330A (ja) 1999-05-11
HUP9801075A2 (hu) 1999-01-28
EP0884054A2 (en) 1998-12-16
EP0884054B1 (en) 2003-04-09
EP0884054B9 (en) 2007-02-14
CN1212869A (zh) 1999-04-07
CZ138198A3 (cs) 1998-12-16
IL124253A (en) 2003-01-12
PL326246A1 (en) 1998-11-23
CA2234899C (en) 2004-08-10
ES2125198B1 (es) 1999-11-16
SK61698A3 (en) 1998-12-02
HU9801075D0 (en) 1998-07-28
SK284337B6 (sk) 2005-02-04
ATE236653T1 (de) 2003-04-15
EP0884054A3 (en) 2000-08-23
ZA983806B (en) 1999-02-19

Similar Documents

Publication Publication Date Title
EE201000020A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
LU92381I2 (fr) Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT)
LU91624I2 (fr) Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS®)
NO996352D0 (no) <Kappa>-antagenist-forbindelser, farmasoeytiske sammensetninger og fremgangsmåte for forebygging og behandling av pruritus
ES2181868T3 (es) Composicion farmaceutica para compuestos de piperidinoalcanol.
DK1915993T3 (da) Synergistiske kombinationer omfattende en renininhibitor til hjertekarsygdomme
HUP0102250A3 (en) Compounds of unstable dipeptidyl peptidase iv inhibitors, pharmaceutical compositions comprising thereof and their use
LU92517I2 (fr) Delamanide et ses dérivés pharmaceutiquement acceptables
EE200000766A (et) Ravimkoostis, mis sisaldab COX-2 inhibiitorit ja iNOS inhibiitorit
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
LU91655I2 (fr) Corifollitropine alfa et ses dérivés pharmaceutiquement acceptables (ELONVA®)
ZA200301039B (en) Inhibitors of alpha4 mediated cell adhesion.
EE03692B1 (et) 19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
HUP0102255A3 (en) Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
DE60014955D1 (de) Schraubzange
NO20024598D0 (no) Farmasöytisk aktive pyrrolidinderivater
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
EP0726072A3 (en) Composition for the treatment of hypertension and congestive heart failure, containing an angiotensin II antagonist and an endopeptidase inhibitor
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
AR011730A1 (es) UNA FORMA FARMACÉUTICA DE CANTIDADES FIJAS DE UN INIHIBIDOR DE LA ENZIMA CONVERSORA DE ANGIOTENSINA Y DE UN ANTAGONISTA DEL CANAL DE CALCIO , COMPOSICIoN FARMACÉUTICAMENTE ACEPTABLE QUE COMPRENDE DICHA FORMA FARMACÉUTICA , PROCEDIMIENTO PARA LA OBTENCIoN DE DICHA COMPOSICIoN FARMACÉUTICAMENTE ACEPTA
WO2001056555A3 (en) Use of cox-2 inhibitors for the treatment of constipation
HUP0103113A3 (en) New pharmaceutical compositions uses for nos inhibitors
CO5070670A1 (es) Taloproteinasas de arilsulfonamidas y estatinas
WO2003020315A1 (fr) Compositions medicinales contenant un antagoniste du recepteur d'angiotensine ii

Legal Events

Date Code Title Description
FG Grant, registration